BAZ2-ICR |
BAZ2-ICR : Antagonist of BAZ2A and BAZ2B
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| BAZ2A |
| |
| BAZ2B |
|
Antagonist
500 nM - 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency: Kd - 1.55 uM
Potency Assay Off-Target:
CEREP, Thermal Shift Assay
Selectivity Assessment Description:
In Cerep screen of 55 receptors, BAZ2-ICR had a clean off-target profile. In thermal shift assay of ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
In FRAP assay, BAZ2-ICR did not displace BRD4 from chromatin.
Selectivity Assessment Description:
In FRAP assay, BAZ2-ICR did not displace BRD4 from chromatin.
Potency Cellular
In Vitro
BAZ2A
Mode of Action: Antagonist
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/jm501963e
BAZ2B
Mode of Action: Antagonist
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/jm501963e
In Vivo Validations
Mouse
Dose: 5 mg/kg
Route of delivery:
Intravenous, Oral
Plasma half life:
0.93 h (IV), 0.90 h (oral)
Systemic clearance:
36.2 mL/min/kg (IV), 36.0 mL/min/kg (oral)
DOI Reference: 10.1021/jm501963e
Chemical Information
| Molecular Formula | C20H19N7 |
| SMILEs | Cn1cc(CCn2cnc(-c3cnn(C)c3)c2-c2ccc(C#N)cc2)cn1 |
| InChI | InChI=1S/C20H19N7/c1-25-12-16(10-23-25)7-8-27-14-22-19(18-11-24-26(2)13-18)20(27)17-5-3-15(9-21)4-6-17/h3-6,10-14H,7-8H2,1-2H3 |
| Molecular weight | 357.17 Da |
| AlogP | 2.7984800000000014 |
| HBond acceptors | 7 |
| HBond donors | -- |
| Atoms | 46 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.